Fosfomycin: A review

Infectious Diseases in Clinical Practice

Volumn 10, Issue 5, 2001, Pages 255-260

  Shrestha, Nabin K ^a   Tomford, J Walton ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOSFOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIURIA; CLINICAL TRIAL; CYSTITIS; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG COST; DRUG EFFICACY; DRUG EXCRETION; DRUG FORMULATION; DRUG INDICATION; DRUG MECHANISM; DRUG TOLERABILITY; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; GASTROINTESTINAL SYMPTOM; HUMAN; PYELONEPHRITIS; SHORT SURVEY; URINARY TRACT INFECTION;

EID: 0034751956     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019048-200106000-00004     Document Type: Short Survey

References (41)

1. Management of urinary tract infections in adults
2. Phosphonomycin, a new antibiotic produced by strains of Streptomyces
3. The mechanism of action of fosfomycin (phosphomycin)
4. The comparative activity of fosfomycin trometamol against organisms isolated from infected urines
5. Fosfomycin tromethamine
6. Pharmacokinetics of fosfomycin
7. Pharmacokinetic profile of fosfomycin trometamol (Monuril)
8. Urinary concentrations of fosfomycin after a single 3 g dose of fosfomycin to elderly nursing-home patients
9. Fosfomycin penetration into the cerebrospinal fluid of patients with bacterial meningitis
10. In vitro susceptibility testing procedures for fosfomycin tromethamine
11. Fosfomycin tromethamine susceptibility of outpatient urine isolates of Escherichiacoli and Enterococcusfaecalis from 10 North American medical centers by three methods
12. In-vitro activity of fosfomycin against vancomycin-resistant enterococci
13. Analysis of oral fosfomycin calcium (Fosmicin) side-effects after marketing
14. Fosfomycin trometamol in treatment of uncomplicated lower urinary tract infections in adult women: Overview
15. Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection
16. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and pyelonephritis in women
17. Fosfomycin trometamol in a single dose versus norfloxacin for seven days in the treatment of uncomplicated urinary tract infections in general practice
18. A comparison between single-dose fosfomycin trometamol (Monurol®) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women
19. Fosfomycin trometamol versus norfloxacin in the treatment of uncomplicated lower urinary tract infections of the elderly
20. Single-dose fosfomycin trometamol (Monuril) versus multiple-dose norfloxacin: Results of a multicenter study in females with uncomplicated lower urinary tract infections
21. Single dose fosfomycin trometamol versus multiple dose norfloxacin over three days for uncomplicated UTI in general practice
22. Treatment of bacteriuria in pregnancy with single dose fosfomycin trometamol: A review
23. Fosfomycin trometamol versus netilmicin in children's lower urinay tract infections
24. The role of fosfomycin trometamol in the management of urinary tract infections in pediatrics
25. Prophylactic chemotherapy with fosfomycin trometamol salt during transurethral prostatic surgery: A controlled multicenter clinical trial
26. Asymptomatic bacteriuria: Which patients should be treated?
27. Treatment of a complicated vancomycin-resistant enterococcal infection with fosfomycin
28. Fosfomycin-ampicillin versus gentamicinampicillin in the treatment of critically ill patients with pneumonia
29. Treatment with a cefotaxime-fosfomycin combination of staphylococcal or enterobacterial meningitis in adults
30. A successful treatment of an infective endocarditis caused by methicillin-resistant Staphylococcus aureus with a combination of cefmetazole and fosfomycin
31. Fosfomycin/metronidazole compared with doxycycline/metronidazole for the prophylaxis of infection after elective colorectal surgery
32. Stratified duration of prophylactic antimicrobial treatment in emergency abdominal surgery
33. Plasmid-encoded fosfomycin resistance in bacteria isolated from the urinary tract in a multicentre survey
34. Plasmid-determined resistance to fosfomycin in Serratia marcescens
35. Formation of an adduct between fosfomycin and glutathione: A new mechanism of antibiotic resistance in bacteria
36. Plasmid-mediated resistance to Staphylococcus epidermidis
37. Susceptibility of frequent urinary pathogens to fosfomycin trometamol and eight other antibiotics: Results of an Italian multicenter survey